Literature DB >> 15983407

Structure of human PNP complexed with ligands.

Fernanda Canduri1, Rafael Guimarães Silva, Denis Marangoni dos Santos, Mário Sérgio Palma, Luiz Augusto Basso, Diógenes Santiago Santos, Walter Filgueira de Azevedo.   

Abstract

Purine nucleoside phosphorylase (PNP) is a key enzyme in the purine-salvage pathway, which allows cells to utilize preformed bases and nucleosides in order to synthesize nucleotides. PNP is specific for purine nucleosides in the beta-configuration and exhibits a strong preference for purines containing a 6-keto group and ribosyl-containing nucleosides relative to the corresponding analogues. PNP was crystallized in complex with ligands and data collection was performed using synchrotron radiation. This work reports the structure of human PNP in complex with guanosine (at 2.80 A resolution), 3'-deoxyguanosine (at 2.86 A resolution) and 8-azaguanine (at 2.85 A resolution). These structures were compared with the PNP-guanine, PNP-inosine and PNP-immucillin-H complexes solved previously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983407     DOI: 10.1107/S0907444905005421

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  11 in total

Review 1.  Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

Authors:  M L Bellows; C A Floudas
Journal:  Curr Drug Targets       Date:  2010-03       Impact factor: 3.465

2.  Unique substrate specificity of purine nucleoside phosphorylases from Thermus thermophilus.

Authors:  Fumiaki Tomoike; Seiki Kuramitsu; Ryoji Masui
Journal:  Extremophiles       Date:  2013-04-02       Impact factor: 2.395

3.  Molecular dynamics studies of a hexameric purine nucleoside phosphorylase.

Authors:  Fernando Berton Zanchi; Rafael Andrade Caceres; Rodrigo Guerino Stabeli; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-08-11       Impact factor: 1.810

Review 4.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

5.  Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis.

Authors:  Ivani Pauli; Luis Fernando Saraiva Macedo Timmers; Rafael Andrade Caceres; Luiz Augusto Basso; Diógenes Santiago Santos; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

6.  Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine.

Authors:  Sepideh Afshar; Michael R Sawaya; Sherie L Morrison
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

7.  Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.

Authors:  Sepideh Afshar; Tsuneaki Asai; Sherie L Morrison
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

8.  Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT.

Authors:  Sepideh Afshar; Tove Olafsen; Anna M Wu; Sherie L Morrison
Journal:  J Exp Clin Cancer Res       Date:  2009-12-03

9.  Insights into phosphate cooperativity and influence of substrate modifications on binding and catalysis of hexameric purine nucleoside phosphorylases.

Authors:  Priscila O de Giuseppe; Nadia H Martins; Andreia N Meza; Camila R dos Santos; Humberto D'Muniz Pereira; Mario T Murakami
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

Review 10.  Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

Authors:  Tadeusz Robak; Anna Korycka; Ewa Lech-Maranda; Pawel Robak
Journal:  Molecules       Date:  2009-03-23       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.